Aravind Dilli Babu: h-index, Total Citations, and Citation Map
Aravind Dilli Babu's h-index is 4 (1 i10-index, 51+ total citations across 5+ publications) according to Google Scholar as of June 2026. Aravind Dilli Babu is affiliated with Cleveland Clinic.
Aravind Dilli Babu is a researcher affiliated with Cleveland Clinic, specializing in Cardiology, Vascular Medicine. Their work has been cited 51 times. This profile visualizes their global influence, highlighting strong citation networks in Brazil.
Aravind Dilli Babu's Citation Metrics
Bibliometric impact based on 5 indexed publications. Of these, 3 are original research articles — the rest are literature highlights, conference abstracts or theses.
- H-Index
- 4
- i10-Index
- 1
- Total Citations
- 51
- Citing Countries
- 18
As of June 2026.
Aravind Dilli Babu has an h-index of 4 and 51 total citations across 5 publications, with research cited by institutions in 18 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Aravind Dilli Babu's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
The current socioeconomic and regulatory landscape of immune effector cell therapies
202425
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher provided a critical 2024 analysis of the socioeconomic and regulatory landscape governing immune effector cell therapies, establishing a foundational framework for understanding current industry constraints.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Aravind Dilli Babu's research
Aravind Dilli Babu is a researcher in Cardiology and Vascular Medicine at Cleveland Clinic. Their work has been cited 51 times across 5 publications (h-index 4), according to Google Scholar.
Their most-cited work, “The current socioeconomic and regulatory landscape of immune effector cell therapies” (2024), has accumulated 25 citations. Other influential works include “Optimal timing of oral anticoagulation initiation in patients with acute ischaemic stroke and atrial fibrillation: A comprehensive meta-analysis and systematic review” (2024) with 6 citations and “Systemic hypertension with VEGFR inhibitor (axitinib) therapy in cancer patients: A meta-analysis and systematic review of randomized controlled trials” (2024) with 5 citations.
Citations of Aravind Dilli Babu's research come primarily from Brazil, United States and China, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
